Coordinated at the Josep Carreras Leukaemia Research Institute by Marcus Buschbeck, INTERCEPT-MDS brings together 10 European public and private expert host institutions to create a European network of experts in leukaemia, epigenetics and single cell genomics.
In addition, we count with the support of 9 partner organizations that will provide state-of-the-art complementary training and a novel educational program in an environment of excellence, innovation and multidisciplinarity.
Josep Carreras Leukaemia Research Institute
Erasmus University Medical Center (Erasmus MC)
Institut national de la sante et de la recherche medicale (Inserm)
Università degli Studi di Firenze (UNIFI)
The Department of Experimental and Clinical Medicine (DMSC) is situated within one of the largest hospitals of Italy and favours the study of clinical cases within internationally-recognized centres of excellence, driving a high-quality level of clinical and experimental research.
Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus (GSH)
Established in 1904, GSH is a public scientific institute performing internationally competitive basic research in the field of tumour biology with a particular focus on the tumour microenvironment. Through close collaboration with clinical partners it is also considered a centre of translational oncology.
Located in Baden-Baden (Germany), Leadership Sculptor focuses on supporting the development of leadership and project management skills in R&D, especially in the life sciences.
Connaître et Combattre les Myélodysplasies (CCM)
Since July 2006, CCM has been supporting people suffering from Myelodysplastic Syndrome and their relatives with the scientific partnership of the Groupe Francophone des Myelodysplasies (GFM).
Universitat Autònoma de Barcelona (UAB)
The UAB is one of the major public universities in Spain. It is recognised for its efforts in promoting quality in teaching, in attracting international talent and in obtaining a growing impact in research.
Aelian Biotechnology is an SME based in Vienna. It combines CRISPR screening with single-cell sequencing, leveraging two transformative technologies to enable genetic screening for complex phenotypes.
GenomeScan is a leading service company in molecular genetics. Based in Leiden (The Netherlands), its main activities are next-generation sequencing (NGS), gene expression analysis, SNP genotyping and methylation analysis.
Université de Paris (UPa)
UPa is a public university in France, fully multidisciplinary in terms of both training and research. Its strategic portfolio of academic partners around the world enables it to offer its students cutting-edge and innovative training courses.
CSIC – Institute for Integrative Systems Biology (I2SysBio)
The I2SysBio is a joint research institute involving Universitat de València (UV) and Agencia Estatal del Consejo Superior de Investigaciones Científicas (CSIC), open to strategic alliances with biotech companies.
University of Florida (UF)
UF is a public research university in Gainesville, (Florida, USA). It is one of sixty-two elected member institutions of the Association of American Universities (AAU), the association of pre-eminent North American research universities, and the only AAU member university in Florida.
Universitätsklinikum Aachen AöR (UKA)
As a maximum-care teaching hospital, the University Clinic RWTH Aachen offers a first-class medicine with a human face. Bundling patient care, research and teaching under one roof – a concept which is unique both architecturally and in terms of organisation – facilitates intensive interdisciplinary dialogue and a dense clinical and scientific network.